Following an abbreviated submission:
valsartan (Diovan®) is accepted for restricted use within NHS Scotland.
Indication under review: treatment of hypertension in children and adolescents 6 to 18 years of age.
SMC restriction: use should be on the recommendation of a paediatric specialist consultant.
The licence for the adult indication pre-dates SMC.
Download detailed advice88KB (PDF)
- Medicine name:
- valsartan (Diovan)
- SMC ID:
- Treatment of hypertension in children and adolescents 6 to 18
- Pharmaceutical company
- Novartis Pharmaceuticals UK Ltd
- BNF chapter
- Cardiovascular system
- Submission type
- Date advice published
- 17 January 2011